Arkolith/Insider Trading/PLX/Form 4

Bashan Dror

PRESIDENT AND CEO, DirectorProtalix BioTherapeutics, Inc. (PLX) · full profile →Form 4 · filed Sep 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 3, 2025Grant(A)195K——2.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 3, 2025Grant(A)340K—$0340K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-023700) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML